| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Medicine,* Renal and Infectious Disease Sections, and the Department of Pathology,¶ Baylor College of Medicine, Houston, Texas; Torrey Pines Biolabs, Houston, Texas; the Department of Medicine, Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, Florida; and the Department of Immunology,|| The Scripps Research Institute, La Jolla, California
The chemokine monocyte chemoattractant protein (MCP)-1 has been implicated in the monocyte/macrophage infiltration that occurs during tubulointerstitial nephritis (TIN). We investigated the role of MCP-1 in rats with TIN by administering a neutralizing anti-MCP-1 antibody (Ab). We observed significantly reduced macrophage infiltration and delayed neutrophil clearance in the kidneys of TIN model rats treated with the anti-MCP-1 Ab. To exclude the possibility that an observed immune complex could affect the resolution of apoptotic neutrophils via the Fc receptor, TIN model rats were treated with a peptide-based MCP-1 receptor antagonist (RA). The MCP-1 RA had effects similar to those of the anti-MCP-1 Ab. In addition, MCP-1 did not affect macrophage-mediated phagocytosis of neutrophils in vitro. Deposition of the anti-MCP-1 Ab in rat kidneys resulted from its binding to heparan sulfate-immobilized MCP-1, as demonstrated by the detection of MCP-1 in both pull-down and immunoprecipitation assays. We conclude that induction of chemokines, specifically MCP-1, in TIN corresponds with leukocyte infiltration and that the anti-MCP-1 Ab formed an immune complex with heparan sulfate-immobilized MCP-1 in the kidney. Antagonism of MCP-1 in TIN by Ab or RA may alter the pathological process, most likely through delayed removal of apoptotic neutrophils in the inflammatory loci.
This article has been cited by other articles:
 |
|
 |
|
  L. Huang, G. Garcia, Y. Lou, Q. Zhou, L. D. Truong, G. DiMattia, X. R. Lan, H. Y. Lan, Y. Wang, and D. Sheikh-Hamad Anti-Inflammatory and Renal Protective Actions of Stanniocalcin-1 in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis Am. J. Pathol., April 1, 2009; 174(4): 1368 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sun, C. O. Martinez, O. Ochoa, L. Ruiz-Willhite, J. R. Bonilla, V. E. Centonze, L. L. Waite, J. E. Michalek, L. M. McManus, and P. K. Shireman Bone marrow-derived cell regulation of skeletal muscle regeneration FASEB J, February 1, 2009; 23(2): 382 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Shireman, V. Contreras-Shannon, O. Ochoa, B. P. Karia, J. E. Michalek, and L. M. McManus MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regeneration J. Leukoc. Biol., March 1, 2007; 81(3): 775 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Frink, A. Lu, B. M. Thobe, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, S. L. Kunkel, and I. H. Chaudry Monocyte chemoattractant protein-1 influences trauma-hemorrhage-induced distal organ damage via regulation of keratinocyte-derived chemokine production Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1110 - R1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Contreras-Shannon, O. Ochoa, S. M. Reyes-Reyna, D. Sun, J. E. Michalek, W. A. Kuziel, L. M. McManus, and P. K. Shireman Fat accumulation with altered inflammation and regeneration in skeletal muscle of CCR2-/- mice following ischemic injury Am J Physiol Cell Physiol, February 1, 2007; 292(2): C953 - C967. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
